Miquel Duran-Frigola

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Venues

Science (New York, N.Y.)

Nature communications

Nature biotechnology

PLOS global public health

IRB Barcelona

This page only lists publications with an associated author ORCID identifier.

Affiliation History

IRB Barcelona Jan 01 2018

Spain

Research Associate :: Structural Bioinformatics and Network Biology

Publications

Fabian Offensperger, Gary Tin, Miquel Duran-Frigola, Elisa Hahn, Sarah Dobner, Christopher W Am Ende, Joseph W Strohbach, Andrea Rukavina, Vincenth Brennsteiner, Kevin Ogilvie, Chakravarthy B N Marella, Katharina Kladnik, Rodolfo Ciuffa, Jaimeen D Majmudar, S Denise Field, Ariel Bensimon, Luca Ferrari, Evandro Ferrada, Amanda Ng, Zhechun Zhang, Gianluca Degliesposti, Andras Boeszoermenyi, Sascha Martens, Robert Stanton, André C Müller, J Thomas Hannich, David Hepworth, Giulio Superti-Furga, Stefan Kubicek, Monica Schenone, Georg E Winter
Large-scale chemoproteomics expedites ligand discovery and predicts ligand behavior in cells. Science (New York, N.Y.) 384 (6694) (2024)
Gemma Turon, Dhanshree Arora, Miquel Duran-Frigola
Infectious Disease Research Laboratories in Africa Are Not Using AI Yet─Large Language Models May Facilitate Adoption. ACS infectious diseases (2024)
Fabian Offensperger, Gary Tin, Miquel Duran-Frigola, Elisa Hahn, Sarah Dobner, Christopher W Am Ende, Joseph W Strohbach, Andrea Rukavina, Vincenth Brennsteiner, Kevin Ogilvie, Chakravarthy B N Marella, Katharina Kladnik, Rodolfo Ciuffa, Jaimeen D Majmudar, S Denise Field, Ariel Bensimon, Luca Ferrari, Evandro Ferrada, Amanda Ng, Zhechun Zhang, Gianluca Degliesposti, Andras Boeszoermenyi, Sascha Martens, Robert Stanton, André C Müller, J Thomas Hannich, David Hepworth, Giulio Superti-Furga, Stefan Kubicek, Monica Schenone, Georg E Winter
Large-scale chemoproteomics expedites ligand discovery and predicts ligand behavior in cells. Science (New York, N.Y.) 384 (6694) (2024)
Gemma Turon, Edwin Tse, Xin Qiu, Matthew H Todd, Miquel Duran-Frigola
Open Source Code Contributions to Global Health: The Case of Antimalarial Drug Discovery. ACS medicinal chemistry letters 15 (9) (2024)
Fabian Offensperger, Gary Tin, Miquel Duran-Frigola, Elisa Hahn, Sarah Dobner, Christopher W Am Ende, Joseph W Strohbach, Andrea Rukavina, Vincenth Brennsteiner, Kevin Ogilvie, Chakravarthy B N Marella, Katharina Kladnik, Rodolfo Ciuffa, Jaimeen D Majmudar, S Denise Field, Ariel Bensimon, Luca Ferrari, Evandro Ferrada, Amanda Ng, Zhechun Zhang, Gianluca Degliesposti, Andras Boeszoermenyi, Sascha Martens, Robert Stanton, André C Müller, J Thomas Hannich, David Hepworth, Giulio Superti-Furga, Stefan Kubicek, Monica Schenone, Georg E Winter
Large-scale chemoproteomics expedites ligand discovery and predicts ligand behavior in cells. Science (New York, N.Y.) 384 (6694) (2024)
Gemma Turon, Jason Hlozek, John G Woodland, Ankur Kumar, Kelly Chibale, Miquel Duran-Frigola
First fully-automated AI/ML virtual screening cascade implemented at a drug discovery centre in Africa. Nature communications 14 (1) (2023)
Ashleigh van Heerden, Gemma Turon, Miquel Duran-Frigola, Nelishia Pillay, Lyn-Marié Birkholtz
Machine Learning Approaches Identify Chemical Features for Stage-Specific Antimalarial Compounds. ACS omega 8 (46) (2023)
Jesse Jake Pry, Michael J Vinikoor, Carolyn Bolton Moore, Monika Roy, Aaloke Mody, Izukanji Sikazwe, Anjali Sharma, Belinda Varaidzo Chihota, Miquel Duran-Frigola, Harriet Daultrey, Jacob Mutale, Andrew D Kerkhoff, Elvin H Geng, Brad H Pollock, Jaime H Vera
Evaluation of kidney function among people living with HIV initiating antiretroviral therapy in Zambia. PLOS global public health 2 (4) (2022)
Adrià Fernández-Torras, Miquel Duran-Frigola, Martino Bertoni, Martina Locatelli, Patrick Aloy
Integrating and formatting biomedical data as pre-calculated knowledge graph embeddings in the Bioteque. Nature communications 13 (1) (2022)
Martino Bertoni, Miquel Duran-Frigola, Pau Badia-I-Mompel, Eduardo Pauls, Modesto Orozco-Ruiz, Oriol Guitart-Pla, Víctor Alcalde, Víctor M Diaz, Antoni Berenguer Llergo, Isabelle Brun Heath, Nuria Villegas, Antonio García de Herreros, Patrick Aloy
Bioactivity descriptors for uncharacterized chemical compounds. Nature communications 12 (1) (2021)
Fidele Ntie-Kang, Kiran K Telukunta, Serge Alain Fobofou, Victor Chukwudi Osamor, Samuel Ayodele Egieyeh, Marilia Valli, Yannick Djoumbou Feunang, Maria Sorokina, Conrad Stork, Neann Mathai, Paul F Zierep, Ana L Chávez-Hernández, Miquel Duran-Frigola, Smith B Babiaka, Romuald Tematio Fouedjou, Donatus Bekindaka Eni, Simeon Akame, Augustine B Arreyetta-Bawak, Oyere Tanyi Ebob, Jonathan A Metuge, Boris Davy Bekono, Mustafa A Isa, Raphael Onuku, Daniel M Shadrack, Thommas Mutemi Musyoka, Vaishali M Patil, Justin Johan Jozias van der Hooft, Vanderlan S Bolzani, José Luis Medina-Franco, Johannes Kirchmair, Tilmann Weber, Ozlem Tastan Bishop, Marnix H Medema, Ludger A A Wessjohann, Jutta Ludwig-Müller
Computational Applications in Secondary Metabolite Discovery (CAiSMD): an online workshop. Journal of cheminformatics 13 (1) (2021)
Miquel Duran-Frigola, Eduardo Pauls, Oriol Guitart-Pla, Martino Bertoni, Víctor Alcalde, David Amat, Teresa Juan-Blanco, Patrick Aloy
Extending the small-molecule similarity principle to all levels of biology with the Chemical Checker. Nature biotechnology 38 (9) (2020)
Miquel Duran-Frigola, Martino Bertoni, Roi Blanco, Víctor Martínez, Eduardo Pauls, Víctor Alcalde, Gemma Turon, Núria Villegas, Adrià Fernández-Torras, Carles Pons, Lídia Mateo, Oriol Guitart-Pla, Pau Badia-I-Mompel, Aleix Gimeno, Nicolas Soler, Isabelle Brun-Heath, Hugo Zaragoza, Patrick Aloy
Bioactivity Profile Similarities to Expand the Repertoire of COVID-19 Drugs. Journal of chemical information and modeling 60 (12) (2020)

Miquel Duran-Frigola.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Miquel Duran-Frigola